Ray Dalio
LEGN icon

Ray Dalio’s Legend Biotech LEGN Stock Holding History

Ray Dalio’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-225,449
Closed -$7.65M – 671
2025
Q1 		$7.65M Buy
225,449
+63,726
+39% +$2.29M 0.04% 300
2024
Q4 		$5.26M Sell
161,723
-4,252
-3% -$176K 0.02% 343
2024
Q3 		$8.09M Buy
165,975
+516
+0.3% +$27.5K 0.05% 299
2024
Q2 		$7.33M Sell
165,459
-43,441
-21% -$2M 0.04% 296
2024
Q1 		$11.7M Sell
208,900
-121,191
-37% -$7.31M 0.06% 230
2023
Q4 		$19.9M Sell
330,091
-22,000
-6% -$1.39M 0.11% 143
2023
Q3 		$23.6M Buy
352,091
+14,606
+4% +$1.01M 0.14% 115
2023
Q2 		$23.3M Buy
337,485
+58,543
+21% +$3.83M 0.14% 116
2023
Q1 		$13.5M Sell
278,942
-174,681
-39% -$8.54M 0.08% 176
2022
Q4 		$22.6M Sell
453,623
-163,727
-27% -$7.93M 0.12% 145
2022
Q3 		$25.2M Buy
617,350
+45,763
+8% +$2.15M 0.13% 133
2022
Q2 		$31.4M Buy
571,587
+28,381
+5% +$1.2M 0.13% 146
2022
Q1 		$19.7M Buy
543,206
+427,047
+368% +$16.9M 0.08% 185
2021
Q4 		$5.41M Buy
+116,159
New +$5.89M 0.03% 278

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ray Dalio's LEGN Position: Q2 2025 in Review

Ray Dalio sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 225,449 shares — an estimated $7.65M sold.

Ray Dalio first reported a position in LEGN in Q4 2021 and held it in 14 quarters. The position peaked at $31.4M in Q2 2022. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Ray Dalio reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Ray Dalio sold 225,449 Legend Biotech shares in Q2 2025, an estimated $7.65M.
  • Ray Dalio first reported a position in Legend Biotech in Q4 2021 and held it in 14 quarters.
  • Ray Dalio's Legend Biotech position peaked at $31.4M in Q2 2022.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Bridgewater Associates's 13F filing for Q2 2025, filed 13 Aug 2025.